Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz… - Ep …, 2015 - academic.oup.com
The current manuscript is an update of the original Practical Guide, published in June 2013
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation …
H Heidbuchel, P Verhamme, M Alings… - European heart …, 2017 - academic.oup.com
Abstract In 2013, the European Heart Rhythm Association (EHRA) published a Practical
Guide on the use of non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation …
Guide on the use of non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation …
EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary
H Heidbuchel, P Verhamme, M Alings… - European heart …, 2013 - academic.oup.com
New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz… - Europace, 2013 - academic.oup.com
New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Non–vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis
KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study
SH Hohnloser, E Basic, M Nabauer - Clinical Research in Cardiology, 2017 - Springer
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are at least as effective
and safe as vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF). All …
and safe as vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF). All …
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF …
Objectives We identified factors associated with thromboembolic and bleeding events in two
contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with …
contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with …
相关搜索
- atrial fibrillation phenprocoumon in patients
- atrial fibrillation european registry
- executive summary antagonist anticoagulants
- atrial fibrillation bleeding events
- atrial fibrillation risk factors
- anticoagulated patients european registry
- atrial fibrillation efficacy and safety
- atrial fibrillation meta analysis
- atrial fibrillation anticoagulated patients
- atrial fibrillation thromboembolic events